MACKENZIE FINANCIAL CORP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 244 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2019. The put-call ratio across all filers is 8.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2021$231,000
+1.3%
4,621
+27.8%
0.00%
Q2 2021$228,000
-2.1%
3,617
-25.0%
0.00%
-100.0%
Q2 2019$233,000
-19.4%
4,820
-15.7%
0.00%0.0%
Q1 2019$289,000
-95.2%
5,720
-95.2%
0.00%
-93.3%
Q2 2018$6,043,000
-4.6%
119,689
-0.5%
0.02%
-6.2%
Q1 2018$6,333,000
+723.5%
120,289
+339.9%
0.02%
+300.0%
Q2 2016$769,00027,3420.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders